Updated Jul 16, 2026
NARACHI MICHAEL has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Michael Narachi is an executive-associated figure linked to Ultragenyx Pharmaceutical Inc. in SEC filings with a most recent date of May 18, 2026. The context confirms an affiliation with Ultragenyx but does not specify his exact role (e.g., director, officer). No additional widely known biographical details are evident from the provided SEC context.
| Role | Insider |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-18 | RARE | Ultragenyx Pharmaceutical Inc. | A — Grant or award | 7.8K | $0.00 |
Michael Narachi is an executive-associated figure linked to Ultragenyx Pharmaceutical Inc. in SEC filings with a most recent date of May 18, 2026. The context confirms an affiliation with Ultragenyx but does not specify his exact role (e.g., director, officer). No additional widely known biographical details are evident from the provided SEC context.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live NARACHI MICHAEL profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.